Treating Depression Using Botulinum Toxin

Michelle Magid, M.D.

Introduction

Dr. Magid attended medical school at Boston University and residency here at Mayo Clinic.  During her time at Mayo, she was Chief resident, colleague of the year, received the Neva M. Peterson award, the Howard P. Rome Grand rounds award, and the AADPRT George Ginsberg fellowship. She was also awarded the Laughlin fellowship by the American college of psychiatrists, and is now a member of the college.  She is currently back in school, and will be graduating with her MBA in 2 months.

After residency, she was recruited to Austin, Texas to build an academic ECT suite for the Seton Hospital Network.  As the Director of ECT Unit for 7 years, the department is now the 3rd largest in the state and continues to grow. 

In 2014, she transitioned to private practice, and is now President of Austin PsychCare and a sub-investigator for Community Clinical Research Inc.

She is affiliated with 4 academic institutions in Texas—UT Southwestern, UT Medical Branch, Texas A&M, and UT Austin, and is involved in developing the psychiatry curriculum for the new medical school in Austin, Texas.

She has a 7 year old son and a 9 year old daughter with her husband, Jason Reichenberg, who is head of Dermatology for the UT Austin Medical School-- together, they subspecialize in Psychodermatology, the interface between the mind and the skin.  They have numerous publishings in this field including a book, “Practical Psychodermatology” which was released last year. 

Dr. Magid received an NIMH young investigator award and a Brain and Behavior Institute research grant to study the Treatment of Depression using Botulinum Toxin, which we will hear about today.  

Learning Objectives

1. Review the major trials that have studied the treatment of depression using Botulinum toxin 
2. Describe the theories behind why botulinum toxin may be beneficial in the treatment of depression
3. Discuss future directions for this treatment intervention.

Live webcast available at:  http://videos.mayo.edu/live

1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  MedHub will be implemented for all post presentation surveys.  Your name and e-mail are not linked to your evaluation. Identifiers are tracked separately for attendance records only.  To document your attendance, please send an email to rstpsychgr@mayo.edu. The badge reader should continue to be utilized for Gonda and Sister Helen Hayes locations.

ACCREDITATION

• Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 
• Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): 

Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry: 

Consultant: Allergan Pharmaceuticals

Grant/Research Support: Brain and Behavior Research Foundation

Honoraria: Ipsen Innovation

 
No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, M.D., Amber Pearson, Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Georgina Rink

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

Allergan Pharmaceuticals – Botulinum Toxin for Depression

Questions regarding this program can be directed to rstpsychgr@mayo.edu.